SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-24-011460
Filing Date
2024-08-08
Accepted
2024-08-08 07:01:24
Documents
70
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 6-K tmb-20240630x6k.htm 6-K 22897
2 EX-99.1 tmb-20240630xex99d1.htm   iXBRL EX-99.1 842123
3 EX-99.2 tmb-20240630xex99d2.htm EX-99.2 441122
  Complete submission text file 0001558370-24-011460.txt   3946446

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20240630.xsd EX-101.SCH 48254
5 EX-101.CAL tmb-20240630_cal.xml EX-101.CAL 42176
6 EX-101.DEF tmb-20240630_def.xml EX-101.DEF 115311
7 EX-101.LAB tmb-20240630_lab.xml EX-101.LAB 269491
8 EX-101.PRE tmb-20240630_pre.xml EX-101.PRE 210195
73 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240630xex99d1_htm.xml XML 478357
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 241185949
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)